Game-Changer: FDA Grants Approval to TOFIDENCE™, a Biosimilar of ACTEMRA® by Bio-Thera Solutions
Bio-Thera Solutions, Ltd. has announced that its partner, Biogen, received FDA approval for TOFIDENCE (tocilizumab-bavi), an intravenous formulation biosimilar referencing ACTEMRA. This marks Bio-Thera’s first … Read more